M

Active Director Director DIN 10170660
DIN 10170660 First appointment Aug 2023 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Monika

Data last updated:

Monika is a Director at Biolga Pharmaceuticals Private Limited (since 2023). The company operates in Business Services. Biolga Pharmaceuticals Private Limited reported revenue of ₹3.9 Lakh (FY 2025).

DIN 10170660
Primary Designation Director
Industry Business Services
First Appointment 29 Aug 2023
Oldest Company Age 4 yrs
Largest company Biolga Pharmaceuticals Private Limited · ₹3.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Aug 20232022₹3.9 Lakh (FY 2025)Active

Board colleagues of Monika

NameDINCompanyDesignation
Vinit Kumar09535634Biolga Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Biolga Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Monika

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Monika

Monika currently holds 1 directorship: Biolga Pharmaceuticals Private Limited (Director, since 29 Aug 2023, revenue ₹3.9 Lakh (FY 2025)).

Monika was first appointed on 29 Aug 2023 as Director at Biolga Pharmaceuticals Private Limited.

The current boards of Monika's companies include Vinit Kumar (Biolga Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available